Effect of lurasidone plus sulpiride on treatment efficacy, psychiatric manifestations, and quality of life among patients with schizophrenia

Table 5 Cognitive and social function assessment of the two patient groups

Indicators	Control group (n = 50)	Observation group (n = 60)	t value	P value
Repeatable battery for the assessment of neuropsychological status (points)
Before treatment	79.36 ± 13.19	78.07 ± 12.39	0.528	0.599
After treatment	87.72 ± 10.04a	95.80 ± 11.09b	3.971	< 0.001
Personal and social performance scale (points)
Before treatment	49.54 ± 4.52	48.80 ± 6.65	0.668	0.505
After treatment	76.94 ± 5.50a	84.17 ± 7.54b	5.642	< 0.001

^aP < 0.05, between the same groups compared with before treatment.

^bP < 0.01, between the same groups compared with before treatment.